Hologic, Inc. HOLX announced an extension of its LOCalizer radiofrequency identification (“RFID”) tag’s CE Mark. Under the extended approval, the tag can now be implanted more than 30 days prior to ...

MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced the granting of a CE Mark to the LOCalizer™ wireless radio frequency identification (RFID) breast lesion localization ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...

Regulators in Europe gave the greenlight to Hologic Inc.’s Localizer, an implanted wireless device that promises to provide doctors greater flexibility to minimize the impact of breast surgery, the ...

Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care The transaction supports Hologic’s strategy to provide a comprehensive suite of ...

Hologic Inc has acquired Somatex Medical Technologies, a provider of biopsy site markers and localization technologies, for approximately $64 million. The company was previously owned by E-Med ...

Hologic Inc. moved to expand its breast surgery line with the acquisition of Endomagnetics Ltd. (Endomag) for a proposed $310 million. Endomag offers a magnetic system that allows precise localization ...